Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
KURA
KURA
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
KURA News
Kura Oncology Grants Stock Options to New Employees
6d ago
Newsfilter
Health Care Stocks Rise 1.4% on NYSE
Apr 17 2026
Yahoo Finance
Kura Oncology Reports Promising Kidney Cancer Trial Results
Apr 17 2026
stocktwits
Kura Oncology Reports Positive Data for Kidney Cancer Drug
Apr 17 2026
seekingalpha
Kura Oncology Reveals New Data on Darlifarnib and Cabozantinib Combination Therapy Potential
Apr 17 2026
Newsfilter
Kura Oncology Presents Darlifarnib Clinical Data at IKCS Europe 2026
Apr 09 2026
Newsfilter
Kura Oncology Grants Stock Options to New Employees
Apr 03 2026
Newsfilter
KURA ONCOLOGY INC: MIZUHO LOWERS TARGET PRICE FROM $30 TO $25
Mar 25 2026
moomoo
Kura Oncology Grants Stock Options to New Employees
Mar 06 2026
Newsfilter
Kura Oncology Reports Q4 2025 Earnings with KOMZIFTI Launch Success
Mar 05 2026
seekingalpha
Kura Oncology Q4 Earnings Miss Expectations
Mar 05 2026
seekingalpha
Kura Oncology Reports Expanded Losses in Q4
Mar 05 2026
NASDAQ.COM
Kura Oncology Set to Announce Q4 Earnings on March 5th
Mar 04 2026
seekingalpha
Kura Oncology Grants Stock Options to New Employees
Feb 06 2026
Newsfilter
Kura Oncology Reports $2.1M KOMZIFTI Revenue in 2025 Financial Results
Jan 12 2026
NASDAQ.COM
Kura Oncology Launches KOMZIFTI, First Once-Daily Oral Menin Inhibitor with $2.1M Initial Revenue
Jan 11 2026
Globenewswire
Show More News
